Plasminogen activator inhibitor-1
Plasminogen Activator Inhibitor-1 (PAI-1)[edit]

Plasminogen Activator Inhibitor-1 (PAI-1) is a protein that plays a crucial role in the regulation of the fibrinolysis system. It is a member of the serpin (serine protease inhibitor) superfamily and is the principal inhibitor of the plasminogen activators, tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA). PAI-1 is encoded by the SERPINE1 gene in humans.
Function[edit]
PAI-1 is primarily involved in the inhibition of fibrinolysis, the process that prevents blood clots from growing and becoming problematic. By inhibiting tPA and uPA, PAI-1 controls the conversion of plasminogen to plasmin, the enzyme responsible for breaking down fibrin clots. This regulation is essential for maintaining the balance between clot formation and dissolution, which is critical for normal hemostasis.
Regulation[edit]
The activity of PAI-1 is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational modifications. Factors such as cytokines, hormones, and growth factors can influence PAI-1 expression. Additionally, PAI-1 activity is modulated by its interaction with other proteins, such as vitronectin, which stabilizes PAI-1 in its active form.
Clinical Significance[edit]

Elevated levels of PAI-1 are associated with an increased risk of thrombosis, as excessive inhibition of fibrinolysis can lead to the persistence of blood clots. This condition is linked to various cardiovascular diseases, including myocardial infarction and stroke. Conversely, PAI-1 deficiency can lead to a bleeding tendency due to excessive fibrinolysis.
PAI-1 is also implicated in metabolic syndrome, obesity, and insulin resistance. It is considered a marker of inflammation and is involved in the pathophysiology of fibrosis and cancer metastasis.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian